Dr. Kathy Jenkins received her medical degree from Harvard Medical and is currently the Senior Associate in Cardiology Research at Boston Children’s Hospital. Dr. Jenkins directs the Cardiology Clinical Research and Regulatory Group, which conducts studies examining variation in outcomes for patients with congenital heart disease and evaluating new therapeutic modalities to treat congenital heart defects. Dr. Jenkins has identified myofibroblastic proliferation as the putative cause for progressive pulmonary vein stenosis, and is running a novel treatment protocol with chemotherapeutic agents.
Kathy’s interest in medicine grew from a young age when her mother shared stories of the inspiring and challenging work she did as a nurse in pediatrics by the passion and commitment that pediatric providers gave towards vulnerable children and families; in pediatric cardiology with the explosion of innovation and new hope, the complexity of anatomy and physiology, and the emotional burden faced by caregivers and families. Dr. Jenkins finds pulmonary vein stenosis (PVS) particularly challenging in all these regards and is making progress with this horrible diagnosis. She is especially proud of their work helping developing world programs achieve the same success we have seen in the United States.